{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-26-000007","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.912052+00:00","generated_at":"2026-05-16T01:54:05.737978+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"ICU Medical Q4: revenue $540.7M (-14% YoY), GAAP loss $(0.64)/share, adj EPS $1.91","bullets":["Revenue $540.7M vs $629.8M in Q4 2024, down 14.1% YoY.","GAAP net loss $(15.7)M, or $(0.64) per diluted share, improving from $(23.8)M loss in Q4 2024.","Adjusted diluted EPS $1.91, down from $2.11; Adjusted EBITDA $98.2M vs $105.5M.","GAAP gross margin improved to 38% from 36%.","Fiscal 2026 guidance provided but numerical details not included in filing excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-26-000007","json":"https://secwatch.observer/filing/0000883984-26-000007.json","markdown":"https://secwatch.observer/filing/0000883984-26-000007.md","text":"https://secwatch.observer/filing/0000883984-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000007/0000883984-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000007/icui-20260219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:54:05.737978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}